Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy: Outcome in patients with locally advanced head and neck cancer

Strahlentherapie und Onkologie

Volumn 189, Issue 8, 2013, Pages 618-624

  Bromme J O ^a   Schmucking M ^a   Arnold, A ^a   Giger, R ^a   Rauch, D ^a   Leiser, D ^a   Plasswilm, L ^b   Geretschlager A ^a   Ghadjar, P ^a   Aebersold, D M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b University of Bern Freiburgstrasse ^*  (Switzerland)

Author keywords

Chemoradiotherapy; Head and neck cancer; Induction chemotherapy; Radiotherapy; Toxicity

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PAIN; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; DERMATITIS; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NUTRITIONAL STATUS; OVERALL SURVIVAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR GROWTH; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRIDGED COMPOUNDS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; TAXOIDS; TREATMENT OUTCOME;

EID: 84881229480     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0397-z     Document Type: Article

References (24)

1. Pignon JP, Maitre A le, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4-14
2. Bourhis J, Overgaard J, Audry H et al (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368:843-854
3. Kubes J, Cvek J, Vondracek V et al (2011) Accelerated radiotherapy with concomitant boost technique (69.5 Gy/5 weeks): an alternative in the treatment of locally advanced head and neck cancer. Strahlenther Onkol 187:651-655
4. Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899
5. Posner MR, Hershock DM, Blajman CR et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705-1715
6. Vermorken JB, Remenar E, Herpen C van et al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695-1704
7. Paccagnella A, Ghi MG, Loreggian L et al (2010) Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Ann Oncol 21:1515-1522
8. Cohen EEW KT, Kocherginsky M, Huang CH et al (2012) DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 30 (suppl., abstr. 5500)
9. Haddad RI RG, Tishler RB, Adkins D et al (2012) The PARADIGM trial: a phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer(LANHC). J Clin Oncol 30 (suppl., abstr. 5501)
10. Zhong LP, Zhang CP, Ren GX et al (2013) Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31:744-751
11. Eisbruch A, Foote RL, O'Sullivan B et al (2002) Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 12:238-249
12. Prestwich RJ, Oksuz DC, Dyker K et al (2011) Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 81:e237-e243
13. Nutting CM, Morden JP, Harrington KJ et al (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127-136
14. Lambrecht M, Nevens D, Nuyts S (2013) Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy: effect on outcome and toxicity in locally advanced head and neck cancer. Strahlenther Onkol
15. Paleri V Patterson J (2010) Use of gastrostomy in head and neck cancer: a systematic review to identify areas for future research. Clin Otolaryngol 35:177-189
16. Fesinmeyer MD, Mehta V, Blough D et al (2010) Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. Int J Radiat Oncol Biol Phys 78:675-681
17. Bourhis J, Sire C, Graff P et al (2012) Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol 13:145-153
18. Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098
19. Van Gestel D, Van Den Weyngaert D, Schrijvers D et al (2011) Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience. Br J Radiol 84:367-374
20. Lorch JH, Goloubeva O, Haddad RI et al (2011) Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 12:153-159
21. Ghadjar P, Simcock M, Studer G et al (2012) Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94). Int J Radiat Oncol Biol Phys 82:524-531
22. Studer G, Lutolf UM, El-Bassiouni M et al (2007) Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncol 46:386-394
23. Studer G, Seifert B Glanzmann C (2008) Prediction of distant metastasis in head neck cancer patients: implications for induction chemotherapy and pre-treatment staging? Strahlenther Onkol 184:580-585
24. Sadat F, Wienke A, Dunst J et al (2012) Survival of patients with head and neck cancer. Impact of physical status and comorbidities. Strahlenther Onkol188:62-70